ArticleFrontiers in oncology2026

Case report: Different outcomes of two cases of relapsed/refractory T cell acute lymphoblastic leukemia treated with anti-CD7 chimeric antigen receptor T cells bridging to allogeneic hematopoietic stem cell transplantation: from curative promise to fatal risk.

Zhijuan Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.